Ani Pharmaceuticals reported $191.4M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Aerie Pharmaceuticals AERI:US $ -72.88M 33.26M
Ani Pharmaceuticals ANIP:US $ 191.4M 0.51M
Aurora Cannabis Inc ACB:CN C$ 2.02B 12.73M
Biodelivery Sciences International BDSI:US $ 122.78M 8.86M
Canopy Growth Corp WEED:CN C$ 4.24B 23.39M
Depomed DEPO:US $ 96.86M 4.6M
Eli Lilly And LLY:US $ 7757M 1312.6M
Emergent Biosolutions EBS:US $ 1522.7M 21M
Endo International Ordinary Shares ENDP:US $ -690.32M 73.28M
Flexion Therapeutics FLXN:US $ -82377000 26.21M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Hikma Pharmaceutical HIK:LN 2.29B 155M
Knight Therapeutics Inc GUD:CN C$ 872.6M 16.84M
Lannett LCI:US $ -47.35M 19.88M
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Novartis NVS:US $ 56771M 2729M
Omeros OMER:US $ -262697000 16.4M
Perrigo Ordinary Shares PRGO:US $ 5182.4M 328.7M
Teva Pharmaceutical TEVA:IT 10.47B 143M
Teva Pharmaceutical Industries TEVA:US $ 10467M 143M